Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis

Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis

The study was aimed at possible increase of the therapy efficacy in patients with advanced tuberculosis by including immunomodulators to the treatment schemes. The data concerning 6034 patients with advanced tuberculosis, mainly fibrocavernous tuberculosis of the lungs, were analysed. Four groups of...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Kolomiets, A. V. Abramov, N. V. Rachina, N. V. Rubleva
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	fibrocavernous pulmonary tuberculosis antituberculosis chemotherapy immunomodulators cycloferon
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/608
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapy and Rehabilitation of Patients with Pulmonary Tuberculosis and Different Treatment Adherence
by: N. V. Rubleva, et al.
Published: (2020-05-01)

Vital and social fears as a target for treatment motivation in patients with pulmonary tuberculosis
by: E. V. Sukhova, et al.
Published: (2014-11-01)

Immunomodulators in Maintenance Therapy of Tuberculosis With Its Patomorphosis Features Taken Into Consideration
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

MINI-ACCESS OSTEOPLASTIC THORACOPLASTY IN THE COMBINATION TREATMENT OF PATIENTS WITH FIBROCAVERNOUS PULMONARY TUBERCULOSIS
by: D. V. Krasnov, et al.
Published: (2014-05-01)

Status of zinc in pulmonary tuberculosis
by: Hassan Ghulam, et al.
Published: (2009-06-01)

Immunomodulators in Therapy of Respiratory Infections
by: V. A. Isakov, et al.
Published: (2020-05-01)

THE COPYING STRATEGIES OF PATENTS WITH FIBROCAVERNOUS PULMONARY TUBERCULOSIS AND THE AREAS OF PSYCHOSOCIAL CORRECTION
by: E. V. Sukhova
Published: (2014-02-01)

Immunomodulators in Combined Therapy of Patients with Chronic Hepatitis
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Accompanying Immunomodulatory Therapy in Treatment of Patients with Neglected Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Early bactericidal activity of sitafloxacin against pulmonary tuberculosis
by: Lihui Nie, et al.
Published: (2025-01-01)

DIFFICULTIES IN THE MANAGEMENT OF A PATIENT WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS CONCURRENT WITH DIABETES MELLITUS
by: T. I. Petrenko, et al.
Published: (2014-05-01)

The effect of immunomodulator azoximer bromide on the cytokine profile in a complex therapy for children with newly diagnosed tuberculosis
by: Yu. V. Mironchuk, et al.
Published: (2022-05-01)

Levofloxacin (Tavanic) in Complex Therapy of Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01)

Effect of Traditional Chinese Medicine on antituberculosis drug therapy for pulmonary tuberculosis and liver function
by: Qing Huang, et al.
Published: (2025-04-01)

Successful treatment of advanced tuberculosis of a single lung with staged correction of post-pneumonectomy syndrome
by: R. V. Tarasov, et al.
Published: (2021-11-01)

A nomogram for predicting unfavorable outcomes of antituberculosis treatment among individuals with AIDS combined with pulmonary tuberculosis in China
by: Xiaoxu Han, et al.
Published: (2025-05-01)

Effectiveness of using Glutamyl-cysteinyl-glycine disodium immunomodulator in patients with destructive multidrug-resistant tuberculosis of lungs
by: A. S. Shalmin, et al.
Published: (2015-08-01)

Causes and Management of Chest Computed Tomography Lesions Progression in Pulmonary Tuberculosis during Antituberculosis Treatment
by: Shuangyin Yang, et al.
Published: (2025-04-01)

Development of real-time pcr technology for the rapid detection of mycobacterium tuberculosis resistance to reserve antituberculosis drugs: fluoroquinolones, amikacin, and capreomycin
by: Yu. S. Alyapkina, et al.
Published: (2014-12-01)

The evolution of the cytokine profile under the influence of immunomodulator glutamine-cystine-glycine disodium in patients with destructive multidrug-resistant lung tuberculosis
by: E. N. Raznatovskaya
Published: (2015-06-01)

EVALUATION OF Xpert MTB/RIF RESULTS AND ANTIBIOTIC SUSCEPTIBILITY RATES IN MYCOBACTERIUM TUBERCULOSIS COMPLEX ISOLATES:FOUR YEARS FOLLOW UP
by: Gizem Niğdelioğlu, et al.
Published: (2024-12-01)

Meglumine Acridonacetate and Complex Therapy of Patients with Newly Identified Advanced Pulmonary Tuberculosis
by: N. S. Pravada, et al.
Published: (2020-05-01)

Shifts in the Heart Left Ventricle Function in Patients with Pulmonary Tuberculosis During Adequate Chemotherapy
by: A. E. Dityatkov, et al.
Published: (2020-05-01)

Prospects of Pharmacogenetic Testing for Design of Algorithms for Personalized Treatment of Tuberculosis of Respiratory Organs in the Astrakhan Region
by: B. I. Kantemirova, et al.
Published: (2020-05-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Risk Factors of Antituberculosis Induced-Hepatotoxicity among HIV/AIDS Patients
by: Lies Luthariana, et al.
Published: (2017-03-01)

Methodology of the Treatment of Pulmonary Tuberculosis
by: Frayt V., et al.
Published: (2013-03-01)

Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation
by: Xue-Xue Zhu, et al.
Published: (2025-05-01)

Local antituberculosis treatment in nonhealing chronic surgical site tuberculosis: A novel approach to cure nonhealing wound!
by: Shital Patil, et al.
Published: (2024-09-01)

Sociodemographic characteristics of patients with pulmonary and extrapulmonary tuberculosis
by: A. V. Osadchiy, et al.
Published: (2015-02-01)

COMPARATIVE STUDIES OF IMMUNOMODULATING PROPERTIES OF C HITOSAN AND ITS DERIVATIVES
by: L. A. Ivanushko, et al.
Published: (2014-07-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Tuberculous endogenous endophthalmitis presenting acute anterior uveitis with hypopyon
by: M. Mejbahul Alam, et al.
Published: (2025-05-01)

Diagnosis and clinical and X-ray characteristics of pulmonary tuberculosis in adolescents
by: M. V. Pavlova, et al.
Published: (2015-01-01)

EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION
by: M. V. Burаkovа, et al.
Published: (2017-12-01)

COMPARATIVE ASSESSMENT OF CHEMOTHERAPY EFFICIENCY MONITORING IN PULMONARY TUBERCULOSIS PATIENTS BY X-RAY EXAMINATION AND DIGITAL TOMOSYNTHESIS
by: M. M. Nikitin, et al.
Published: (2016-12-01)

Experience of using rifapentine in continuation phase of treatment of adult tuberculosis cases
by: T. I. Morozova, et al.
Published: (2019-07-01)

Development of pulmonary tuberculosis in the patient with systemic sarcoidosis and brain involvement
by: E. V. Korzh, et al.
Published: (2021-11-01)

A case of Tuberculosis in the Patient after Orthotopic Heart Transplantation
by: T. V. Pyanzova, et al.
Published: (2021-09-01)